| An outbreak of synthetic cannabinoid–associated coagulopathy in Illinois AH Kelkar, NA Smith, A Martial, H Moole, MD Tarantino, JC Roberts New England journal of medicine 379 (13), 1216-1223, 2018 | 85 | 2018 |
| Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar AH Kelkar, JA Blake, K Cherabuddi, H Cornett, BL McKee, CR Cogle Healthcare 9 (3), 351, 2021 | 72 | 2021 |
| Inferior vena cava filters: a framework for evidence-based use AH Kelkar, A Rajasekhar Hematology 2014, the American Society of Hematology Education Program Book …, 2020 | 31 | 2020 |
| high cost of chimeric antigen receptor T-cells: challenges and solutions ERS Cliff, AH Kelkar, DA Russler-Germain, FA Tessema, AJN Raymakers, ... American Society of Clinical Oncology Educational Book 43, e397912, 2023 | 16 | 2023 |
| Venous thromboembolism related to cytomegalovirus infection: a case report and literature review AH Kelkar, KS Jacob, EB Yousif, JJ Farrell Medicine 96 (51), e9336, 2017 | 16 | 2017 |
| Impact of the COVID-19 pandemic on colorectal and prostate cancer screening in a large US health system AH Kelkar, J Zhao, S Wang, CR Cogle Healthcare 10 (2), 264, 2022 | 14 | 2022 |
| The democratization of scientific conferences: Twitter in the era of COVID-19 and beyond R Banerjee, AH Kelkar, AC Logan, NS Majhail, N Pemmaraju Current hematologic malignancy reports 16, 132-139, 2021 | 12 | 2021 |
| Immune checkpoint inhibitor-associated thrombotic thrombocytopenic purpura in a patient with metastatic non-small-cell lung cancer S De Filippis, C Moore, K Ezell, K Aggarwal, AH Kelkar Cureus 13 (6), 2021 | 11 | 2021 |
| Cytomegalovirus-associated venous and arterial thrombotic disease AH Kelkar, BL Loc, MD Tarantino, A Rajasekhar, H Wang, M Kelkar, ... Cureus 12 (12), 2020 | 11 | 2020 |
| Synthetic control arms in studies of multiple myeloma and diffuse large B‐cell lymphoma R Banerjee, S Midha, AH Kelkar, A Goodman, V Prasad, GR Mohyuddin British Journal of Haematology 196 (5), 1274-1277, 2022 | 10 | 2022 |
| Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and … JJ Auletta, N Khera, P DeMartino, AH Kelkar, RA Yusuf, SM Davies, ... Transplantation and Cellular Therapy 29 (11), 713-720, 2023 | 8 | 2023 |
| An unusual association between hemophagocytic lymphohistiocytosis, mixed connective tissue disease, and autoimmune hemolytic anemia: A case report AH Kelkar, AA Shah, SL Yong, Z Ahmed Medicine 96 (28), e7488, 2017 | 7 | 2017 |
| A case report of delayed return of spontaneous circulation: Lazarus phenomenon JW Meeker, AH Kelkar, BL Loc, TJ Lynch The American Journal of Medicine 129 (12), e343-e344, 2016 | 7 | 2016 |
| The impact of pre-apheresis health related quality of life on peripheral blood progenitor cell yield and donor's health and outcome: secondary analysis of patient-reported … N Farhadfar, KW Ahn, S Bo-Subait, B Logan, HE Stefanski, JW Hsu, ... Transplantation and cellular therapy 28 (9), 603. e1-603. e7, 2022 | 6 | 2022 |
| Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study HL Amonoo, LE Harnedy, EC Deary, L Traeger, LA Brown, EP Daskalakis, ... Bone Marrow Transplantation 57 (8), 1277-1286, 2022 | 5 | 2022 |
| Racial and socioeconomic disparities in long-term outcomes in≥ 1 year allogeneic hematopoietic cell transplantation survivors: a CIBMTR analysis BJ Blue, R Brazauskas, K Chen, S Hashmi, LE Lehmann, WA Wood, ... Blood 138, 3929, 2021 | 5 | 2021 |
| Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis M Kandula, AH Kelkar, N Liberio, MK Aiyer Journal of Community Hospital Internal Medicine Perspectives 6 (6), 33383, 2016 | 5 | 2016 |
| Recommendations from the ICM-VTE: General J Parvizi, AA Abbas, O Abcha, MS Abdelaal, PW Ackermann, AJ Acuña, ... Journal of Bone and Joint Surgery-Series A 104, 4-162, 2022 | 4 | 2022 |
| Cancer in the time of coronavirus: a call for crisis oncology standards of care AH Kelkar, CR Cogle Healthcare 8 (3), 214, 2020 | 4 | 2020 |
| Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease—Estimating the True Value S Mattke JAMA neurology 79 (11), 1204-1205, 2022 | 3 | 2022 |
Michael Tarantino, MDThe Bleeding and Clotting Disorders InstituteVerified email at ilbcdi.org
